Asset Details

  • Description:
  • Mean free plasma concentration‐time profiles of Ro44–3888 after oral administration of sibrafiban (2 mg twice daily) alone (◆) or in combination (●) with ticlopidine (250 mg twice daily) and aspirin (80 mg twice daily) for 7 days. Data are expressedas mean±standard deviation of the mean.
  • License:
  • Rights Managed
  • Rights Holder:
  • John Wiley & Sons, Inc.
  • License Rights Holder:
  • Asset Type:
  • Image
  • Asset Subtype:
  • Chart/Graph
  • Image Orientation:
  • Landscape
  • Image Dimensions:
  • 300 x 203
  • Image File Size:
  • 7.51 KB
  • Creator:
  • Bärbel Wittke,, Hilary Ensor,, Jain Chung,, Herbert Birnböck,, Berthold Lausecker,, Sylvie I. Ertel,, Ian J. Mackie, Samuel J. Machin
  • Credit:
  • Wittke,, B., Ensor,, H., Chung,, J., Birnböck,, H., Lausecker,, B., Ertel,, S. I., Mackie, I. J., & Machin, S. J. (2000). Pharmacokinetics and pharmacodynamics of sibrafiban alone or in combination with ticlopidine and aspirin. British Journal of Clinical Pharmacology, 49(3), 231-239. https://doi.org/10.1046/j.1365-2125.2000.049003231.x.
  • Collection:
  • Keywords:
  • Restrictions:
  • Property Release:
  • No
  • Model Release:
  • No
  • Purchasable:
  • Yes
  • Sensitive Materials:
  • No
  • Article Authors:
  • Bärbel Wittke,, Hilary Ensor,, Jain Chung,, Herbert Birnböck,, Berthold Lausecker,, Sylvie I. Ertel,, Ian J. Mackie, Samuel J. Machin
  • Article Copyright Year:
  • 2000
  • Publication Volume:
  • 49
  • Publication Issue:
  • 3
  • Publication Date:
  • 03/01/2000
  • DOI:
  • https://doi.org/10.1046/j.1365-2125.2000.049003231.x

Click on image to enlarge

Would you like to download this asset? Tell us more and we can generate a quote, license and downloadable file.

Add to Cart